B. Riley Securities Reiterates Buy on Wave Life Sciences, Lowers Price Target to $18

Benzinga · 6d ago
B. Riley Securities analyst Madison El-Saadi reiterates Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $22 to $18.